SS31 Ameliorates Sepsis-Induced Heart Injury by Inhibiting Oxidative Stress and Inflammation
- PDF / 2,395,023 Bytes
- 11 Pages / 595.276 x 790.866 pts Page_size
- 106 Downloads / 186 Views
ORIGINAL ARTICLE
SS31 Ameliorates Sepsis-Induced Heart Injury by Inhibiting Oxidative Stress and Inflammation Yue Liu,1 Wenjian Yang,1 Xiaodong Sun,1 Lixia Xie,1 Yi Yang,1 Ming Sang,1 and Rong Jiao
1,2
Abstract— Sepsis-induced myocardial dysfunction (SIMD), lack of effective treatment, ac-
counts for high mortality of sepsis. Mitochondrion-targeted antioxidant peptide SS31 has been revealed to be responsible for certain cardiovascular disease by ameliorating oxidative stress injury. But whether it protects a septic heart remains little known. This study sought to prove that SS31 was capable of improving sepsis-induced myocardial dysfunction dramatically. C57BL/6 mice were intraperitoneally administered lipopolysaccharide (LPS), exposed to systemic inflammation. Thirty-five C57BL/6 mice were randomly divided into four groups: sham group, LPS group (5 mg/kg), SS31 group (5 mg/kg), and SS31 + LPS group (treatment group). Heart tissues were harvested for pathological examination at the indicated time points. H9C2 cell were treated with LPS with or without the presence of SS31 (10 μM) at 37 °C to assess the effect on cardiomyocytes at the indicated time points. SS31 restored myocardial morphological damage and suppressed inflammatory response as evidenced by significantly decreasing the mRNA levels of IL-6, IL-1β, and TNF-α in vitro and in vivo. In addition, myocardial energy deficiency secondary to sepsis was remarkedly ameliorated by SS31. Furthermore, we found that SS-31 normalized the activity of malondialdehyde, glutathione peroxidase, and superoxide dismutase in vitro and in vivo, and maintained mitochondrial membrane potential (MMP) as well. And western blot was applied to measure the expressions of p-p38MAPK, p-JNK1/2, p-ERK, p62, and NF-κB p65; the results illuminated that the cardioprotective effect of SS31 was partly linked to NF-κB. In conclusion, SS31 therapy effectively protected the heart against LPS-induced cardiac damage. KEY WORDS: SS31; SIMD; mitochondria; inflammation; oxidative stress.
Yue Liu, Wenjian Yang, Xiaodong Sun, Lixia Xie, Yi Yang, Ming Sang and Rong Jiao contributed equally to this work.
INTRODUCTION
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s10753-019-01081-3) contains supplementary material, which is available to authorized users.
Sepsis is a lethal syndrome caused by a series of inappropriate immune responses [1, 2], which is responsible for million deaths annually [3, 4]. Sepsis may develop into a kind of systemic inflammatory response syndrome (SIRS) without properly and promptly control, eventually leading to multiple organ dysfunction (MOD). Sepsisinduced cardiomyopathy (SIC) is one of common complications of sepsis, characterized by high morbidity and mortality [5]. Patients with cardiac dysfunction are
1
Department of Pediatrics, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, No. 15 Jiefang Road, Xiangyang, 441000, Hubei Province, People’s Republic of China 2 To whom correspondence should be addressed
Data Loading...
